NCT01622153

Brief Summary

  1. 1.The investigator hypothesize that the Laser pulpotomy will provide adequate and comparable success clinically in primary molars.
  2. 2.The investigators hypothesize that the Laser pulpotomy will provide adequate and comparable success radiographically in primary molars.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
120

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jun 2011

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2011

Completed
1 year until next milestone

First Submitted

Initial submission to the registry

June 14, 2012

Completed
4 days until next milestone

First Posted

Study publicly available on registry

June 18, 2012

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2014

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2014

Completed
Last Updated

May 10, 2017

Status Verified

May 1, 2017

Enrollment Period

3 years

First QC Date

June 14, 2012

Last Update Submit

May 9, 2017

Conditions

Outcome Measures

Primary Outcomes (1)

  • Radiographic

    Failure is identified as radiographic: furcation radiolucency, external root resorption

    6, 12, and 18 months

Secondary Outcomes (1)

  • Clinical

    6, 12, 18 months

Study Arms (2)

Formocresol (control)

PLACEBO COMPARATOR

This will consist of patients who are ASA I or II status, 3-8 years old, males and females, and present with restorable primary molars with reversible pulpitis and free of clinical radiographic signs of pulp pathology. From these study participants, they will be randomly assigned to this or other group. Patients in this group will receive a pulpotomy. Cotton pellets are saturated with conventional 1:5 dilution of Buckley's formocresol into the canal orifice for 5 minutes for complete hemostasis. IRM (Zinc Oxide Eugenol) cement will then be placed to seal the pulp chamber. A stainless steel crown will be cemented with Ketac Cement that was triturated for 10 seconds to complete the pulpotomy procedure and final restoration.

Procedure: Formocresol application after pulpotomy preparation

Laser

ACTIVE COMPARATOR

This will consist of patients who are ASA I or II status, 3-8 years old, males and females, and present with restorable primary molars with reversible pulpitis and free of clinical radiographic signs of pulp pathology. From these study participants, they will be randomly assigned to this or other group. Patients in this group will receive a pulpotomy. Then a GENTLEray 980 Soft Tissue diode laser (Power: 3.0W, Mode: PW, Fiber: 300µm, Ton: 100ms, Toff: 100ms, Timer: cont) will be used to vaporize the residual pulp tissue and complete hemostasis. IRM (Zinc Oxide Eugenol) cement is then placed to seal the pulp chamber. A stainless steel crown cemented with Ketac Cement for the full coverage final restoration completes the pulpotomy procedure.

Procedure: GENTLEray 980 Soft Tissue diode laser

Interventions

1:5 Buckley's Formocresol dilution applied for 5 minutes or until hemostasis achieved

Also known as: Buckley's solution, baby root canal, primary root canal
Formocresol (control)

Application to pulp chamber until hemostasis achieved

Also known as: soft tissue laser, electrosurgery, baby root canal
Laser

Eligibility Criteria

Age3 Years - 8 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Restorable carious primary molars with reversible pulpitis and free of clinical or radiographic signs of pulp pathology
  • Males and females
  • Children ages 3-8 years old
  • Children classified under ASA I or II status

You may not qualify if:

  • Excluded will be primary molars with clinical or radiographic signs of pathology
  • Children not within age range
  • Absence of parent/caregiver
  • Mentally disabled parent/caregiver
  • Patients not returning for 6 month and 12 month follow up examination appointment

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University Hospital-Rainbow Babies & Children's Hospital

Cleveland, Ohio, 44106, United States

Location

MeSH Terms

Interventions

Electrosurgery

Intervention Hierarchy (Ancestors)

Surgical Procedures, Operative

Study Officials

  • Gerald A Ferretti, DDS, MS, MPH

    University Hospitals Cleveland Medical Center

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Chair of Pediatric Dentistry

Study Record Dates

First Submitted

June 14, 2012

First Posted

June 18, 2012

Study Start

June 1, 2011

Primary Completion

June 1, 2014

Study Completion

June 1, 2014

Last Updated

May 10, 2017

Record last verified: 2017-05

Locations